Unlock stock picks and a broker-level newsfeed that powers Wall Street.
NYSE - Nasdaq Real Time Price USD

Oscar Health, Inc. (OSCR)

Compare
13.28
-0.02
(-0.11%)
As of 3:24:50 PM EDT. Market Open.
Loading Chart for OSCR
  • Previous Close 13.30
  • Open 12.95
  • Bid 13.31 x 800
  • Ask 13.32 x 800
  • Day's Range 12.62 - 13.35
  • 52 Week Range 12.43 - 23.79
  • Volume 2,153,858
  • Avg. Volume 4,623,316
  • Market Cap (intraday) 3.329B
  • Beta (5Y Monthly) 1.75
  • PE Ratio (TTM) 132.85
  • EPS (TTM) 0.10
  • Earnings Date May 5, 2025 - May 9, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 19.36

Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

www.hioscar.com

2,400

Full Time Employees

December 31

Fiscal Year Ends

Recent News: OSCR

View More

Performance Overview: OSCR

Trailing total returns as of 3/31/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

OSCR
1.15%
S&P 500 (^GSPC)
4.62%

1-Year Return

OSCR
10.66%
S&P 500 (^GSPC)
6.77%

3-Year Return

OSCR
33.25%
S&P 500 (^GSPC)
23.83%

5-Year Return

OSCR
63.10%
S&P 500 (^GSPC)
117.05%

Compare To: OSCR

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: OSCR

View More

Valuation Measures

Annual
As of 3/28/2025
  • Market Cap

    3.33B

  • Enterprise Value

    2.10B

  • Trailing P/E

    133.00

  • Forward P/E

    18.69

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.39

  • Price/Book (mrq)

    3.29

  • Enterprise Value/Revenue

    0.23

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.28%

  • Return on Assets (ttm)

    0.85%

  • Return on Equity (ttm)

    2.87%

  • Revenue (ttm)

    9.18B

  • Net Income Avi to Common (ttm)

    25.43M

  • Diluted EPS (ttm)

    0.10

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.15B

  • Total Debt/Equity (mrq)

    36.77%

  • Levered Free Cash Flow (ttm)

    1.04B

Research Analysis: OSCR

View More

Company Insights: OSCR

Research Reports: OSCR

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.